Biotech beauty ingredient market growth underlined by Ginkgo Bioworks and Twist Bioscience deal

Biotech beauty ingredient market growth underlined by Ginkgo Bioworks and Twist Bioscience deal

Biotech innovations require industry-scale resources to get alternative ingredients for fragrance and personal care to market. As that market grows, synthetic DNA manufacturing, like what Twist Bioscience does, is in greater demand.

Ginkgo Bioworks engineers organisms like yeast, putting biotech to work making ingredients like lactones for perfume producer Robertet. “Because many yeasts already produce lactones, [for this project] we designed the yeast to produce the lactones more efficiently,” Christina Agapakis, creative director at Ginkgo Bioworks told Cosmetics Design when that project was announced.

“As yeast grows, it ferments sugar into alcohol and many of the flavors that are found in beer. By engineering the yeast with enzymes from plants,” she explained, “our strains can produce different flavors and fragrances, which can then be extracted from the cells and used in perfumes and other products.”

To do this sort of work Ginkgo needs millions of base pairs of synthetic DNA (which is made up of gene-length de novo sequences). And, that’s where Twist Bioscience comes in.

Now

The deal, announced today by San Franciscobased Twist Bioscience, has the company delivering a minimum of 400 million base pairs of synthetic DNA to Ginkgo by December 2017.

Ginkgo and Twist have worked together before. In fact, Ginkgo was one of the company’s Beta access customers. “We've already received millions of bases on-time and on-spec from Twist Bioscience in the first several months of our partnership,” Jason Kelly, CEO and co-founder of Ginkgo Bioworks, tells the press. “We're excited about how quickly they're scaling their DNA synthesis technology and infrastructure that we're already tripling our order for next year.”

And in the future

Ginkgo sees outsourced in vitro DNA construction as the way forward. “If your company is still cloning by hand you're missing out on a big opportunity,” says Kelly.

And the relationship with Twist is shaping up to be a lasting one: “We are thrilled to support Ginkgo in their significant growth and unprecedented success both through our current agreement and their escalating demand through 2017,” Emily M. Leproust, CEO of Twist Bioscience, remarked in the company’s press release about the new deal.

“As we expand our product offering to include longer genes and a diversified product mix, we look forward to serving Ginkgo's future growth beyond 2017, where the rapid scalability of our high throughput silicon platform will enable our customers to work with unparalleled quantities of synthetic DNA, driving new applications and innovative scientific developments.”

Related News

(image courtesy of Ginkgo Bioworks)

More cultured ingredients coming to beauty, thanks to Ginkgo - Amyris partnership

Current state of silicones: new white paper

Current state of silicones: new white paper

image of Bioworks2 courtesy of the company

Biotechnology leader Ginkgo Bioworks opens enormous new foundry

Ginkgo Bioworks new partnerships focus on enzyme production

Ginkgo Bioworks new partnerships focus on enzyme production

cultured fragrance ingredients (photo courtesy of Ginkgo Bioworks)

Ginkgo Bioworks and Robertet to develop new fragrance ingredients

Cosmetic ingredients from synthetic DNA deal between Gen9 and Amyris

Cosmetic ingredients to result from synthetic DNA deal between Gen9 and Amyris

Applied DNA Sciences to grow its cosmetics, fragrances, and personal care business

Applied DNA Sciences to grow its cosmetics, fragrances, and personal care business

Changing the face of luxury skin care with consumer genetics

Changing the face of luxury skin care with consumer genetics

Related Products

See more related products